Researchers at Moffitt Cancer Center, working with colleagues at The University of Arizona and Arizona State University, have developed a new combination agent approach targeting tumor receptors based on their variety of cell surface proteins. The approach, which was tested in pancreatic cancers and melanoma modeled in tumor-bearing mice, opens the possibility of developing new multivalent agents that can target unique and multiple receptor combinations in tumor cells. This is a significant improvement over current single-target strategies.
Recent PostsMonday, October 13, 2014
The University of Florida’s Multi-functional Integrated System Technology (MIST) Center will play a leading role in researching the next generation of “smart” electronics funded by a National Science Foundation program that combines federal money with industry investments in strategic research. ..Read More ⇒Sunday, October 12, 2014
VGTI Florida, a leading, non-profit biomedical research institute, announced the launch of its Center for Diseases of Aging (“CDA”), a major initiative to accelerate the discovery and advancement of novel, best-in-class healthcare interventions for the prevention and treatment of diseases commonly associated with aging. ..Read More ⇒Friday, October 10, 2014
Researchers at the University of Central Florida set a new record in funded research in FY14, receiving $145.6 million, 30 percent more than the previous year. The funding totals reflect successful collaborations with industry, a record total for federal defense grants and continued growth in commercialization and innovation activity. ..Read More ⇒Thursday, October 09, 2014
A team of scientists led by Sanford-Burnham’s Ranjan J Perera, Ph.D., has identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients, but not in normal healthy individuals. The study sets the stage for the development of more-sensitive and specific non-invasive tests for prostate cancer than those currently available, which could result in fewer unnecessary prostate biopsies with less treatment-related morbidity, according to a new study in The Journal of Molecular Diagnostics. ..Read More ⇒Wednesday, October 08, 2014
The University of Florida announced today the formation of the UF Diabetes Institute, a collaboration of dozens of researchers campuswide all focused on forging advances in treatment for a disease that afflicts an estimated 29.1 million Americans and 1 in 10 Floridians. ..Read More ⇒
TagsUniversity of Central Florida consumers BioFlorida neuroscience Draper Sanford-Burnham robotics computer science Embry-Riddle agriculture grants University of North Florida innovation magnets ecology Florida Power & Light economy Jackson Lab health care medical AxoGen animals commercialization Florida Institute of Technology ICFO nanotechnology business cancer health conference / event Florida Atlantic University Max Planck Florida International Univ. clean energy University of West Florida aging stem cell sciences aerospace AGTC biotechnology FL Institute for Commercialization of Public Research green technology biomedical astronomy Scripps Research Institute engineering partnerships marine education technology HIV/AIDS Torrey Pines Institute photonics society/culture Florida State University University of Florida environment physics Moffitt Cancer Center children accreditation Univeristy of South Florida Florida Hospital Nanotheraputics Florida Gulf Coast Univ. research research policy policy VGTI University of Miami Nova Southeastern Univ. energy FAMU Florida Trend materials science Enterprise Florida awards IHMC bioscience GrowFL accounting sustainability life science gender accolades Banyan Biomarkers